BioSpace News Archive

BioCapital

Cartesian Therapeutics to Participate in Upcoming March 2024 Investor Conferences

Cartesian Therapeutics, Inc., a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, announced that its management expects to participate in the following investor conferences in March.

March 6, 2024
·
1 min read
Business

TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

TScan Therapeutics, Inc. reported financial results for the three months and full year ended December 31, 2023, and provided a business update.

March 6, 2024
·
14 min read
Genetown

Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024

Omega Therapeutics, Inc. announced that it will present two posters at the American Association for Cancer Research Annual Meeting 2024, taking place in San Diego, California, April 5 – 10, 2024.

March 6, 2024
·
5 min read
Business

InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

InspireMD, Inc., developer of the CGuard™ Embolic Prevention System for the treatment of carotid artery disease and prevention of stroke, announced financial and operating results for the fourth quarter and full-year ended December 31, 2023.

March 6, 2024
·
15 min read
BioMidwest

Kraig Biocraft Laboratories Preparing Additional Business Investment License to Advance its Business Operations

Kraig Biocraft Laboratories, Inc., announces that it is preparing a second business investment application in Vietnam as part of the planned expansion of its business operations.

March 6, 2024
·
2 min read
Biotech Bay

Olema Oncology Announces Publication of Data Highlighting Palazestrant’s Ability to Inhibit Wild-Type and Mutant ER+ Breast Cancer Both as Monotherapy and in Combination with CDK4/6 Inhibitors

Olema Pharmaceuticals, Inc. announced that Molecular Cancer Therapeutics, an American Association for Cancer Research journal, has selected as a featured article a data publication that describes the distinct properties of palazestrant.

March 6, 2024
·
5 min read
Business

iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors

iTeos Therapeutics, Inc. announced the appointment of Jill DeSimone to its Board of Directors, effective March 7, 2024, where she will serve on the Company’s audit committee.

March 6, 2024
·
5 min read
Drug Development

Medicenna to Provide Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming American Association for Cancer Research Annual Meeting

Medicenna Therapeutics Corp., a clinical-stage immunotherapy company focused on the development of Superkines, announced that two posters will be presented at the American Association for Cancer Research Annual Meeting 2024, taking place in San Diego, CA from April 5-10, 2024.

March 6, 2024
·
5 min read
Business

iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates

iTeos Therapeutics, Inc. reported financial results for the fourth quarter and full year ended December 31, 2023 and provided a business update.

March 6, 2024
·
11 min read
Business

CytoSorbents to Report Fiscal 2023 Operating and Financial Results

CytoSorbents Corporation, a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, will report fiscal 2023 financial results on Thursday, March 14th, 2024 at 4:30PM EDT.

March 6, 2024
·
5 min read